A comprehensive review on Plumbago zeylanica linn

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 25, 2011, Pages 2738-2747

  Mandavkar, Yuvaraj D ^a   Jalalpure, Sunil S ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

Author keywords

Pharmacological activities; Phytochemistry; Plumbago zeylanica

Indexed keywords

30 O BETA GLUCOPYRANOSYL PLUMBAGIC ACID; 30 O BETA GLUCOPYRANOSYL PLUMBAGIC ACID METHYLESTER; 3BETA HYDROXYLUP 20(29) ENE 27,28 DIOIC ACID; ACETYLSALICYLIC ACID; ACORUS CALAMUS EXTRACT; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; EMBLICA OFFICINALIS EXTRACT; HEMIDESMUS INDICUS EXTRACT; HERBACEOUS AGENT; IMMUNOMODULATING AGENT; PLUMBAGIN; PLUMBAGO ZEYLANICA EXTRACT; SESELIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTHELMINTIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; ARTHRITIS; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG MECHANISM; DRUG STRUCTURE; FEMALE INFERTILITY; GENOTOXICITY; HUMAN; HYPERLIPIDEMIA; IMMUNOMODULATION; INSECTICIDAL ACTIVITY; LIVER PROTECTION; LIVER TOXICITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PAW EDEMA; PERITONITIS; PLANT STRUCTURES; PLUMBAGO ZEYLANICA; PROMYELOCYTIC LEUKEMIA; REVIEW; TISSUE INJURY;

EID: 84855795018     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: 10.5897/AJPP11.739     Document Type: Review

References (61)

1. Akintonwa A, Awodele O, Afolayan G, Herbert AB (2009). Coker Mutagenic screening of some commonly used medicinal plants in Nigeria. J. Ethnopharmacol., 125: 461-470.
2. Alpana R (1996). Effect of Plumbago zeylanica in hyperlipidaemic rabbits and its modification by vitamin E. Indian J. Pharmaco., 28: 161-166.
3. Anonymous (1989). The Wealth of India. Publication and Information directorate. CSIR. New Delhi, 3: 163-164.
4. Aqil F, Ahmad I (2007). Antibacterial properties of traditionally used Indian medicinal plants. Methods Find Exp. Clin. Pharmacol., 29(2): 79-92.
5. Aqil F, Ahmad I, Owais M (2006). Evaluation of anti-methicillin-resistant Staphylococcus aureus (MRSA) activity and synergy of some bioactive plant extracts. Biotechnol. J., 1(10): 1093-1102.
6. Aqil F, Zahin M., Ahmad I (2008). Antimutagenic activity of methanolic extracts of four ayurvedic medicinal plants. Indian J Exp Biol 46(9): 668-672.
7. Aziz MH, Dreckschmidt NE, Verma AK (2008). Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer. Cancer Res., 68(21): 9024-9032.
8. Bhattacharjee SK (1998). Handbook of Medicinal Plants. Pointer Publishers, pp. 274.
9. Bopaiah CP, Pradhan N (2001). Central nervous system stimulatory action from the root extract of Plumbago zeylanica in rats. Phytother. Res., 15: 153-156.
10. Checker R, Sharma D, Sandur SK, Khanam S, Poduval TB (2009). Antiinflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes. Int. Immunopharmacol., 9(7-8): 949-958.
11. Chen CA, Chang HH, Kao CY, Tsai TH, Chen YJ (2009). Plumbagin, isolated from Plumbago zeylanica, induces cell death through apoptosis in human pancreatic cancer cells. Pancreatology, 9(6): 797-809.
12. Chen YC, Tsai WJ, Wu MH, Lin LC, Kuo YC (2007). Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-kappaB. Br. J. Pharmacol., 150(3): 298-312.
13. Chen ZF, Tan MX, Liu LM, Liu YC, Wang HS, Yang B, Peng Y, Liu HG, Liang H, Orvig C (2009). Cytotoxicity of the traditional chinese medicine (TCM) plumbagin in its copper chemistry. Dalton Trans., 28: 10824-10833.
14. Chen ZF, Tan MX, Liu YC, Peng Y, Wang HH, Liu HG, Liang H (2011). Synthesis, characterization and preliminary cytotoxicity evaluation of five Lanthanide (III)-Plumbagin complexes. J. Inorganic Biochem., 105: 308-316.
15. Chetty KM, Sivaji K, Sudarsanam G, Hindu SP (2006). Pharmaceutical studies and therapeutic uses of Plumbago zeylanica Roots. Ethnobotanical Leaflets, 10: 294-304.
16. Dang GK, Parekar RR, Kamat SK, Scindia AM, Rege NN (2011). Antiinflammatory activity of Phyllanthus emblica, Plumbago zeylanica and Cyperus rotundus in acute models of inflammation. Phytother. Res., 25(6): 904-908.
17. Demma J, Hallberg K, Hellman B (2009). Genotoxicity of plumbagin and its effects on catechol and NQNO-induced DNA damage in mouse lymphoma cells. Toxicol. In Vitro, 23(2): 266-271.
18. Demma JE, Engidawork B, Hellman (2009). Potential genotoxicity of plant extracts used in Ethiopian traditional medicine. J. Ethnopharmacol., 122: 136-142.
19. Edwin S, Joshi SB, Jain DC (2009). Antifertility activity of leaves of Plumbago zeylanica in female albino rats. Eur. J. Contracept Reprod. Health Care, 14(3): 233-239.
20. Elizabeth M (2002). Williamson Major Herbs of Ayurveda, p. 239.
21. Giday M, Teklehaymanot T, Animut A, Mekonnen Y (2007). Medicinal plants of the Shinasha, Agew-awi and Amhara peoples in northwest Ethiopia. J. Ethnopharmacol., 110(3): 516-525.
22. Hsieh YJ, Lin LC, Tsai TH (2006). Measurement and pharmacokinetic study of plumbagin in a conscious freely moving rat using liquid chromatography/tandem mass spectrometry. J. Chromatogr. B, 844: 1-5.
23. Iqbal A, Aqil F (2007). In vitro efficacy of bioactive extracts of 15 medicinal plants against ESβL-producing multidrug-resistant enteric bacteria. Microbiol. Res., 162: 264-275
24. Jetty A, Subhakar C, Rajagopal D, Jetty M, Subramanyam M, Murthy MM (2010).-Antimicrobial activities of neo-and 1-epineo-isoshinanolones from Plumbago zeylanica roots. Pharm. Biol., 48(9): 1007-1011.
25. Kamal MA, Rao PR (1995).-Modulatory effect of plumbagin (5-hydroxy- 2-methyl-1,4-naphthoquinone) on macrophage functions in BALB/c mice. I. Potentiation of macrophage bactericidal activity. Immunopharmacology, 30: 231-236.
26. nd ed-4, p. 532.
27. Kishore N, Mishra BB, Tiwari VK, Tripathi V (2010). Difuranonaphthoquinones from Plumbago-zeylanica roots. Phytochem. Lett., 3: 62-65.
28. Kofi A, Dickson R, Mensah A, Fleischer TC (2009). Acaricidal effect of Plumbago zeylanica L. Against Amblyoma variegatum. Pharmacog. J., 1: 190-194.
29. Kumar R, Kumar S, Patra A, Jayalakshmi S (2009). Hepatoprotective activity of aerial parts of Plumbago zeylanica linn against carbon tetrachloride-induced hepatotoxicity in rats. Int. J. Pharma. Pharm. Sci., 1: 171-175.
30. Lemma H, Debella A, Addis G, Kunert, Geyid A, Teka F, Yersaw K (2002). Anti-bacterial activity of Plumbago zeylanica L. roots on some pneumonia causing pathogens. Ethiop. J. Sci., 25: 285-295.
31. Lin LC, Yang LL, Chou CJ (2003). Cytotoxic naphthoquinones and plumbagic acid glucosides from Plumbago zeylanica. Phytochemistry, 62: 619-622.
32. Mallikadevi T, Paulsamy S (2010). Plumbago zeylanica- a potential plant for antimicrobial activity. Plant Arch., 10: 547-550.
33. Maniafu BM, Wilber L, Ndiege IO, Wanjala CC, Akenga TA (2009). Larvicidal activity of extracts from three Plumbago spp against A. gambiae. Mem Inst Oswaldo Cruz, 104(6): 813-817.
34. Mittal V, Sharma SK, Kaushik D, Khatri M, Tomar K (2010). A comparative study of analgesic activity of Plumbago zeylanica Linn. callus and root extracts in experimental mice. Res. J. Pharm. Biol. Chem. Sci., 1: 830-836
35. Nadakarni AK, Nadakarni KR (1999). Indian-Materia Medica. Popular Prakashan; Bombay, p. 564.
36. Natarajan KS, Madhusudhanan N, Shanmugasundaram KR, Shanmugasundaram ERB (2006). Antioxidant activity of a salt- spice-herbal mixture against free radical induction. J. Ethnopharmacol., 105: 76-83.
37. Nazeem S, Azmi AS, Hanif S, Ahmad A, Mohammad RM, Hadi SM, Kumar KS (2009). Plumbagin induces cell death through a copper- redox cycle mechanism in human cancer cells. Mutagenesis, 24(5): 413-418.
38. Neubert R. Schmidt PC, Wutzler P, Schmidtke M (2006). Antiviral activities of some Ethiopian medicinal plants used for the treatment of dermatological disorders. J. Ethnopharmacol., 104: 182-187.
39. Okamoto I, Doi H, Kotani E, Takeya T (2001). The aryl-aryl coupling reaction of 1-naphthol with SnCl4 for 2,2′-binaphthol synthesis and its application to the biomimetic synthesis of binaphthoquinone isolated from Plumbago zeylanica. Tetrahedron Lett., 42: 2987-2989.
40. Olagunju JA, Jobi AA, Oyedapo OO (1999). An investigation into the biochemical basis of the observed hyperglycaemia in rats treated with ethanol root extract of Plumbag ozeylanica. Phytother. Res., 13: 346-348.
41. Patil CD, Patil SV, Salunke BK, Salunkhe RB (2011). Bioefficacy of Plumbago zeylanica (Plumbaginaceae) and Cestrum nocturnum (Solanaceae) plant Extracts against Aedesaegypti (Diptera: Culicide) and-Poecili areticulata. Parasitol. Res., 108(5): 1253-1263.
42. Patil SV, Patil CD, Salunkhe RB, Salunke BK (2010). Larvicidal activities of six plants extracts against two mosquito species, Aedesa egypti and Anopheles stephensi. Trop. Biomed., 3: 360-5.
43. Poosarla, Athota RR (2007). Alleviation of Collagen-induced Arthritis by Plumbago zeylanica in Mice. Pharma. Bio., 45: 54-59.
44. Powolny AA, Shingh SV (2008).-Plumbagin-induced Apoptosis in Human Prostate Cancer Cells is Associated with Modulation of Cellular Redox Status and Generation of Reactive Oxygen Species. Pharm. Res., 25: 2171-2181.
45. Reddy JS, Rao RP, Reddy MS (2002). Wound healing effects of Heliotropium indicum, Plumbago zeylanicum and Acalypha indica in rats. J. Ethnopharmacol., 79: 249-251.
46. Sakamoto S, Putalun W, Tsuchihashi R, Morimoto S, Kinjo J, Tanaka H (2008). Development of an enzyme-linked immunosorbent assay (ELISA) using highly-specific monoclonal antibodies against plumbagin. Anal. Chim. Acta., 607: 100-105.
47. Sakamoto S, Taura F, Tsuchihashi R, Putalun W, Kinjo J, Tanaka H, Morimoto S (2010). Expression, purification, and characterization of anti-plumbagin single-chain variable fragment antibody in Sf9 insect cell. Hybridoma Larchmt, 29(6): 481-488.
48. Sandur SK, Pandey MK, Sung B, Aggarwal BB (2010). 5-hydroxy-2-methyl-1,4-naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: potential role in chemosensitization. Mol. Cancer Res., 8(1): 107-118.
49. Sathya S, Sudhagar S, Murugan VP, Rajaganapathy BR, Velusamy SM, Niranjali SD, Baddireddi SL (2010). 3β-Hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester, a novel natural product from Plumbago zeylanica inhibits the proliferation and migration of MDA- MB-231 cells. Chemico-Biological Interactions, 188: 412-420.
50. Sheeja E, Joshi SB, Jain DC (2010). Bioassay-guided isolation of anti- inflammatory and antinociceptive compound from Plumbago zeylanica leaf. Pharm. Biol., 48(4): 381-387.
51. Simonsen HT, Nordskjold JB, Smitt UW, Nyman U, Palpu P, Joshi P, Varughese G (2001). In vitro screening of Indian medicinal plants for antiplasmodial activity. J. Ethnopharmacol., 74: 195-204.
52. Sudhakar SR, Unnikrishnan KP, Indira BA (2008). Reverse Phase HPLC-UV and HPTLC Methods for Determination of Plumbagin in Plumbag oindica and Plumbago zeylanica. Indian J. Pharm. Sci., 8: 44-47.
53. Teshome K, Mariam TG, Asres K, Perry F, Engidawork E (2008). Toxicity studies on dermal application of plant extract of Plumbagozeylanica used in Ethiopian traditional medicine. J. Ethnopharmacol., 117: 236-248.
54. Tsai WJ Chenc YC, Wuc MH, Lina LC, Chuangd KA, Change SC, Kuog YC (2008). Seselin from Plumbagozeylanica inhibits phytohemagglutinin (PHA)-stimulated cell proliferation in human peripheral blood mononuclear cells. J. Ethnopharmacol., 119: 67-73.
55. Vishnukanta L, Rana AC (2010). Evaluation of anti-convulasant activity of Plumbago zeylanica Linn leaf extract. Asian J. Pharm. Clin. Res., 3: 76-78.
56. W ang YC, Huang TL (2005). Anti-Helicobacter pylori activity of Plumbago zeylanica L. J. Chromatograph A, 1094: 99-104.
57. W ang YC, Huang TL (2005). Screening of anti-Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS-Immunol. Med. Microbiol., 43: 295-300.
58. Xu KH, Lu DP (2010). Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo. Leuk Res., 34: 658-665.
59. Yang SJ, Chang SC, Wen HC, Chen Ching-Yu, Jyh-Fei Liao, Chang CH (2010). Plumbagin activates ERK1/2 and Akt via superoxide, Src and PI3-kinase in 3T3-L1 Cells. Eur. J. Pharmacol., 638: 21-28.
60. Yedapo (1996). Studies on bioactivity of the root extract of Plumbago zeylanica. Pharm. Biol., 34: 365-369.
61. Zahin M, Aqil F, Ahmad I (2009). The in vitro antioxidant activity and total phenolic content of four Indian medicinal plants. Int. J. Pharma. Pharm. Sci., 1: 89-95.